Poly(ADP-ribose)polymerase (PARP, EC 2.4,2.30), an abundant nuclear protein activated by DNA nicks, mediates cell death in vitro by nicotinamide adenine dinucleo tide (NAD) depletion after exposure to nitric oxide. The authors examined whether genetic deletion of PARP (PARP null mice) or its pharmacologic inhibition by 3-aminobenzamide (3-AB) attenuates tissue injury after transient cerebral ischemia. Twenty-two hours after reperfusion following 2 hours of fila mentous middle cerebral artery occlusion, ischemic injury was decreased in PARP-I-and PARP+I-mice compared with PARP+I+ litter mates, and also was attenuated in l29/SV wild type mice after 3-AB treatment compared with controls. Infarct sparing was accom � anied by functional recovery in PARP-Iand 3-AB-treated mice. Increased poly(ADP-ribose) immuno staining observed in ischemic cell nuclei 5 minutes after reper fusion was reduced by 3-AB treatment. Levels of NAD-the substrate of P ARP-were reduced 2 hours after reperfusion and were 35% of contralateral levels at 24 hours. The decreases
were attenuated in PARP-Imice and in 3-AB-treated animals.
Poly(ADP-ribose)polymerase cleavage by caspase-3 (CPP-32) has been proposed as an important step in apoptotic cell death.
Markers of apoptosis, such as oligonucleosomal DNA damage, total DNA fragmentation, and the density of terminal deoxy nucleotidyl transferase dUTP nick-end-labelled (TUNEL +) cells, however, did not differ in ischemic brain tissue of PARP-I-mice or in 3-AB-treated animals versus controls, al though there were differences in the number of TUNEL-stained cells reflecting the decrease in infarct size. Thus, ischemic brain injury activates P ARP and contributes to cell death most likely by NAD depletion and energy failure, although the au thors have not excluded a role for PARP in apoptotic cell death at earlier or later stages in ischemic cell death. Inhibitors of PARP activation could provide a potential therapy in acute stroke. Key Words: Apoptosis-Cerebral ischemia-DNA damage-Energy depletion-Mice-Poly(ADP-ribose) polymerase.
tachment of ADP-ribose subunits from its substrate, nic otinamide adenine dinucleotide (NAD), to numerous nuclear proteins, including PARP itself. Formation of poly(ADP-ribose) is a unique post-translational modifi cation that can be induced by DNA strand breaks after exposure to nitric oxide (NO) or oxygen-free radicals (de Murcia et aI., 1992 (de Murcia et aI., , 1994 Lindahl et aI., 1995; Shall, 1995) .
The "PARP suicide hypothesis" states that excessive poly(ADP-ribose) formation due to PARP activation by DNA strand breaks and subsequent depletion of its sub strate NAD might contribute to cell death through an energy failure mechanism. This may explain the neuro toxic properties of NO (Zhang et aI., 1994) and why pancreatic islet cells die after exposure to reactive oxy gen species (ROI) in vitro (Radons et aI., 1994) . In fact, inhibitors of PARP, such as 3-aminobenzamide (3-AB), can partially prevent NO and ROI cytotoxicity in neuro nal and pancreatic cells, Nitric oxide and ROI formed during ischemiaJreperfusion are known DNA-damaging agents and are potent mediators of cell death (Beckman et aI., 1990) .
Recently, PARP was recognized as a substrate of ac tivated caspase-3 (CPP-32), a mammalian homologue of the C. elegans ced-3 death gene, during apoptosis (Tew ari et al., 1995; Nicholson et a!., 1995) . The role of PARP in apoptosis, however, remains unclear and somewhat controversial. On the one hand, cleaved P ARP appears to facilitate apoptosis, possibly by interrupting DNA bind ing and repair at an earlier step than internucleosomal DNA fragmentation (Patel et a!., 1996) . Cleavage de creases PARP enzymatic activity and could facilitate DNA laddering by upregulating Ca2+/Mg2+-dependent endonuclease as a consequence of reduced poly(ADP ribosyl)ation (Yoshihara et a!., 1975 , Nicholson et a!., 1995 . However, inhibition of poly(ADP-ribosyl)ation of histone HI by 3-AB abolishes internucleosomal DNA fragmentation in vitro (Y oon et a!., 1996) . Treatment with enzymatic inhibitors of P ARP reportedly blocked or augmented apoptosis, depending on the paradigm (Kauf mann et a!., 1994).
In the present study, we analyzed the function of P ARP in cerebral ischemia in vivo by studying the ef fects of transient focal cerebral ischemia in P ARP null mice and after 3-AB treatment, a widely used, nonselec tive P ARP inhibitor. Poly(ADP-ribose )polymerase null mice are phenotypically normal and develop without ob vious behavioral defects. Although DNA repair is effi cient after ultraviolet or alkylating agents, primary fibro blasts proliferate more slowly. Moreover, the mice are susceptible to epidermal hyperplasia . Heller et a!. (1995) demonstrated that 3-AB prevents ROI and NO cytotoxicity in P ARP+ I + but not in P ARP-Iislet cells in vitro, identifying P ARP as the target of 3-AB-' s cytoprotective effects.
We show in the present study that P ARP deletion or inhibition of P ARP enzyme activity promotes resistance to ischemic brain injury after middle cerebral artery oc clusion (MCAO). We further measured poly(ADP ribose) formation and NAD levels in ischemic tissue as well as markers of apoptosis in ischemic tissue to deci pher the mechanism by which activation of PARP me diates ischemic brain injury.
METHODS

Physiology
Regional cerebral blood flow was measured by laser Doppler f10wmetry (PF2B, Perimed, Stockholm, Sweden), along with arterial blood pressure and heart rate, as described (Hara et a!., 1996 (Hara et a!., , 1997a 
Ischemia Model
Adult male 129/SV mice (18-20 g, Taconic farm, German town, NY, U.S.A.) were anesthetized for induction with 1.5% halothane and maintained in 1,0% halothane in 70% nitrous oxide (N20) and 30% oxygen (02) using a Fluotec 3 vaporizer (Colonial Medical, Amherst, NH, U,S.A.) . PARP+ mice and P ARP+I-and +1+ litter mates (generated and genotyped by Dr.
Wang at the Institute of Molecular Pathology, Vienna, as de scribed in Wang et aI., 1995) were anesthetized with 0.1 mL chloral hydrate (7% w/w in phosphate-buffered saline [PBS] given intraperitoneally). Ischemia was induced by occlusion with a 8-0 nylon monofilament coated with resinihardener mix ture (Xantopren and Elastomer Activator, Bayer Dental, Osaka, Japan) as described previously (Hara et a!., 1996) . For filament withdrawal after 2 hours of ischemia, the animals were reanes thetized briefly with halothane. Twenty-two hours after reper fusion, animals were killed and the brains were frozen imme diately in 2-methylbutane on dry ice for cryostat sections or directly divided into five coronal 2-mm sections using a mouse 
Neurological Deficits
Mice were tested for Neurological deficits and scored as described by Bederson et a!. (1986) with the following minor modifications (Hara et a!., 1996) : 0 = no observable Neuro logical deficit (normal); 1 = failure to extent right forepaw (mild); 2 = circling to the contralateral side (moderate); and 3 = loss of walking or righting reflex (severe), Animals were rated by the operator and by a second rater blinded to the treatment protocol and group identity, Assessments were made after 30 minutes and after 24 hours.
Poly(ADP-ribose) Immunohistochemistry
Rabbit polyclonal antisera directed against purified poly (ADP-ribose) was provided by Dr. Kunihiro Ueda (Kyoto Uni versity), The antibody is specific for poly(ADP-ribose), and immunoreactivity reflects both the number of ADP ribosylation sites and poly(ADP-ribose) chain length (Ikai et aI., 1980) , Mice were anesthetized with sodium pentobarbital (100 mg/kg intraperitoneally) and transcardially perfused with 4% para formaldehyde, After immediate removal, brains were stored in the same buffer containing 20% sucrose, and free-floating sec tions (40 fLm) were prepared on a freezing microtome, Immu nohistochemistry was performed according to a three-stage avi din-biotin method with biotinylated goat antirabbit immuno globulin G as secondary antibody and 3'-3'-diaminobenzidine as chromogene. The 3'-3' -diaminobenzidine reaction was in tensified with 0.04% nickel chloride. The poly(ADP-ribose) polyclonal antibody was used at a concentration of 1: 100,
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Negative controls were performed by omission of either the primary or secondary antiserum.
Nicotinamide Adenine Dinucleotide Determination
For in vitro measurements, animals were killed and the brains were removed immediately and cut into five coronal 2-mm slices. Tissue was obtained from within the ischemic zone in the third and fourth coronal section (4-8 mm) and snap-frozen. The samples were weighed, and the tissue was disrupted by freezing and thawing followed by homogenization in 4 x volumes PBS. The homogenate was centrifuged for 20 minutes at 15,000 x g at 4°C, and the supernatant was stored at -70°C until further use (Heller et aI., 1995) . Cellular NAD was determined by an enzymatic cycling method using a�cohol de hydrogenase (Boehringer Mannheim, Mannheim, Germany) from Saccharomyces cerevisiae, as described previously (Nisslbaum and Green, 1969) . Levels in ischemic tissue are expressed as percent Of contralateral side. Contralateral values were stable at 0.00744 ± 0.00135 units/minute per milligram of tissue and did not differ between groups (pARP+I+, PARP-I-, 3-AB, PBS). For validation, NAD was added to homogenate prepared from ischemic and control tissue. Measurements in creased linearly by addition of external NAD to the homog enate.
For qualitative in situ analysis, we adapted the method for tissue sections. The reaction mixture needed for enzymatic cy cling was added to a 2% low-melt agarose solution at 45°C. 
DNA Analysis
For DNA analysis, samples were prepared from the ischemic area and contralateral hemisphere at 24 hours. The brain was cut with a brain matrix, and the second (2-4 mm) slice was placed on a chilled glass plate. Tissue preparation was per formed under a dissecting microscope, and only tissue from within the pale ischemic area was isolated for DNA prepara tion; corresponding tissue was taken from the contralateral side.
For quantitation of DNA damage, a terminal deoxynucleo tidyl transferase-dependent isotopic end-labelling method was used (Tilly and Hsueh, 1993) with minor modifications as de scribed previously (Hara et al., 1997b) . Three micrograms of DNA were used in the labelling procedure together with 35 ng of a 100-base pair DNA fragment as the internal standard. The DNA was electrophoresed on a 2.0% agarose gel (agarose 3: 1, Arnresco, Solon, OH, U.S.A.), autoradiographed together with a radioactive standard, and analyzed with the M4 image analy sis system. DNA less than 10 kilobase was used as an index of total DNA fragmentation. To measure oligonucleosomal dam age more specifically, laddered DNA <1000 base was mea sured by summing the areas of each peak (areas under the curve) minus baseline densitometry readings. The method of quantitation was validated using an artificial "smear-ladder" system in which smeared DNA was obtained by extracting DNA from a decapitated mouse brain incubated at 3rC for 48 hours (MacManus et aI., 1996) . In a total amount of 1 j.Lg of DNA, 0.02, 0.04, 0.08, and 0.12 j.Lg of a commercially avail able 200-bp ladder (Invitrogen, Carlsbad, CA, U.S.A.) was added to a constant amount of smeared DNA. In another ex periment, increasing amounts of smeared DNA (0.3, 0.5, 0.7, 0.9 j.Lg) were added to a constant amount of ladder (0.1 j.Lg).
The readings for "total DNA fragmentation" and "oligo nucleosomal damage" were related linearly to the amount of total (smeared) and laddered DNA (error < 10%).
Statistical Analysis
Data are presented as mean ± standard deviation. Statistical comparisons were made by two-tailed Student's t-test (infarct size, DNA quantitation) or by two-way analysis of variance followed by Student's t test (NAD determination) or one-way analysis of variance followed by Tukey test (physiology) or Dunnett's test (regional cerebral blood flow). For Neurological deficits, the Mann-Whitney rank sum test was applied to com pare two groups, and Kruskal-Wallis one-way analysis of vari ance on ranks followed by Dunnett's test was used for three groups. Analysis was made using the software EXCEL (Mi crosoft, Redmond, WA, U.S.A.) or SigmaStat (Jandel, Corpo ration, San Rafael, CA, U.S.A.). P < 0.05 was considered sta tistically significant.
RESULTS
Physiologic Data
No significant differences in mean arterial blood pres sure, heart rate, RCBF, or arterial blood gases were de tected between 3-AB-and vehicle-treated 129/SV mice (n = 5 per group; Table 1). Regional cerebral blood flow Mean arterial blood pressure (MABP) was measured before, during, and until 60 minutes after ischemia. Fifty microliter blood samples were withdrawn twice, before ischemia and just before reperfusion. Data are represented as mean ± SD. There are no significant differences between groups. MeA, middle cerebral artery; rCBF, regional cerebral blood flow. decreased to less than 20% of baseline immediately after MCAO and sustained during 2 hours of ischemia. After reperfusion, RCBF increased to 90% to 100% of baseline within 5 minutes.
Ischemic Infarction in Poly(ADP-Ribose)Polymerase
Null Mice
Twenty-two hours after reperfusion, direct infarct vol ume was significantly smaller in P ARP null mice (n = 8) and P ARP heterozygotes (n = 8) compared with wild-type litter mates (n = 8; Fig. I A) . Infarction area was significantly smaller in all five coronal sections in P ARP null mice and in section 5 in P ARP heterozygote mice compared with wild-type litter mates (Fig. 1 B) . PBS 3-AB rological score of 2 or higher 30 minutes after the onset of ischemia and after animals recovered from anesthesia. At 24 hours, the deficit was significantly smaller in PARP null mice compared with wild-type mice (0.7 ± 0.9 vs. 1.6 ± 0.8, P < 0.01). The deficit was less but did not reach statistical significance in the P ARP heterozy gote mice (1.0 ± 0.8 vs. 1.6 ± 0.8).
Infarction Volume in 3-Aminobenzamide-Treated Animals 3-aminobenzamide pretreatment (n = 8) significantly reduced direct infarct volume and area (sections 1-4) in 129/SV mice compared with PBS-injected control mice (n = 7) 22 hours after reperfusion (Figs. 1C and lD) . Also, infarct volume determined indirectly was signifi cantly smaller (50.6 ± 12.0 mm3 vs. 94.3 ± 19.2 mm3, P < 0.01). Neurological deficits were significantly im- with their respective controls 22 hours after 2-hour middle cerebral artery occlusion. Brain infarct volume (A) and brain infarct area (2-mm coronal sections) (8) were decreased in PARP-I-(diamonds) and PARP+I-(squares) compared with PARP+I+ mice (triangles). Brain infarct volume (C) and infarct areas (0) were reduced after 3-AB (squares) compared with vehicle treatment (diamonds). 3aminobenzamide (0.4 iJmol) was injected intracerebroventricularly 10 minutes before ischemia. Data are presented as mean ± standard deviation (n = 7-8/group). * P < 0.05 vs. vehicle.
proved in 3-AB-treated animals (1.3 ± 0.5 vs. 2.3 ± 0.5, P < 0.05).
Poly(ADP-Ribose) Formation
To analyze PARP activation after ischemia, poly (ADP-ribose) immunohistochemistry was performed. The number of poly(ADP-ribose) positive cells that could be identified clearly by specific nuclear staining increased two-to threefold in the ischemic tissue com pared with the contralateral side 5 minutes after reper fusion following 2-hour ischemia. Also, the intensity of staining per cell was increased. Positive cells frequently showed swelling and nuclear disruption as early signs of cell damage. Poly(ADP-ribose) formation after MCAO and reperfusion was inhibited strongly by 3-AB (Fig. 2) ; staining was not detected in P ARP null mice. After longer periods of reperfusion (3 or 6 hours) after 2-hour ischemia, or after I-hour ischemia without reperfusion, increased poly(ADP-ribose) formation was not observed (not shown).
Nicotinamide Adenine Dinucleotide Determination
Brain levels of NAD did not differ under basal con ditions between P ARP null mice and wild-type litter mates and 3-AB versus vehicle-treated controls as as sessed both in vitro and in vivo. Levels of NAD de creased to approximately 35% within the ischemic terri tory at 24 hours in vehicle-treated and P ARP+/+ mice. Higher NAD levels were measured in ischemic territory of P ARP null mice compared with wild-type (n = 5 in duplicate per group), and in 3-AB-treated mice com pared with vehicle controls (n = 4 in duplicate per group) after 24 hours ( Fig. 3B and D) .
Decreased NAD staining was observed in the middle cerebral artery territory as early as 2 hours after recircu lation and was further decreased at 4 and 6 hours (Fig. 4) . The decrease was attenuated after 3-AB treatment (Fig.  4) . The decreased NAD staining preceded gross morpho logic damage on hematoxylin and eosin stained sections (not shown).
FIG. 2. Poly (ADP-ribose) immunoreactivity was increased in ischemic tissue 5 minutes after reperfusion following 2-hour middle cerebral artery occlusion. Poly (ADP-ribose) was visualized using a polyclonal poly (ADP-ribose) antibody. (A) Low and (B) higher magnification of i schemic tissue (vehicle-group); (C) low and (0) higher magnification of ischemic tissue after 3-aminobenzamide (3-AB) treatment (see Fig. 1 ). Cells show nuclear staining, prominent in the margins of the nucleus (indicated by arrows, B) . The number of poly (ADP-ribose) positive cells and the intensity of staining per cell was increased in ischemic tissue (A, B) compared with the contralateral side (not shown). Pretreatment with 3-AB (C, 0) inhibited formation of poly (ADP-ribose) compared with the vehicle group (A, B) . Staining was not detected in PARP-I-mice (not shown, see also Wang et aI., 1995) . Scale bar = 1 mm (A, C), 250 !Jm (B, 0). (Tilly and Hsueh, 1993) . Un its are IJCi/m L x b (see also Methods). No sign ificant di fferences were detected between PARP null mice and 3-AB-treated mice vs. their respect ive controls. Nicotinamide adenine dinucleo ti de was measured with an enzymatic cycling method according to Nisslbaum et al. (1969) . Values are given as percent of control (contralateral hem isphere). Signif icant differences were seen between PARP null mice and 3-AB-treated an imals and their respective controls. * P < 0.05.
DNA Damage and Oligonucleosomal Fragmentation
(Laddering) TUNEL( +) cells were present in great numbers throughout the ischemic tissue in all animals at 24 hours, especially in the peri-infarct zone (n = 3 for PARP-Iand + 1 +, 3-AB-and vehicle-treated mice). Many of these cells showed typical features of apoptosis. The lesion areas containing TUNEL( +) cells were smaller in PARP-I -mice and 3-AB-treated animals compared with their controls, matching smaller infarction areas as de termined by hematoxylin & eosin staining on adjacent sections (data not shown). Estimates of cell density within the ischemic area were made in animals from all four groups at the level of the anterior commissure and 2 mm posterior to the anterior commissure. No difference in cell density within the ischemic area was found be tween groups when evaluated by two observers blinded to the treatment groups. Brain tissue from within the ischemic zone from PARP null mice, 3-AB-treated animals, and controls ex hibited DNA laddering on agarose gels (Fig. 5) . Total DNA fragmentation did not differ between P ARP null mice (n = 5) and wild-type litter mates (n = 5) after 24 hours. Moreover, 3-AB-treated mice (n = 6) did not J Cereb Blood Flow Metab, Vol. 17, No. /1, 1997 differ from vehicle-treated controls (n = 5) after 24 hours (Figs. 4A and 4C) . The amount of laddered DNA (oligonucleosomal damage) did not differ between P ARP-I -and + 1 + at 24 hours (20 ± 6 vs. 22 ± 16 /-LCi/mL x b, n = 5) and 3-AB-treated mice compared with con trols at 24 hours (30 ± 11 vs. 24 ± 14 /-LCi/mL x b, n = 6 or 5).
DNA fragmentation and DNA laddering also did not differ in 3-AB-treated animals compared with controls at 12 and 72 hours (n = 3 each). DNA fragmentation at 12 hours was 4250 ± 1770 versus 4110 ± 13 10 /-LCi/mL x b and DNA laddering was 13 ± 3 versus 16 ± 12 /-LCi/mL x b (3-AB vs. PBS, respectively). DNA fragmentation at 72 hours was 23,700 ± 6450 versus 20,740 ± 9210 /-LCi! mL x b, and DNA laddering was 61 ± 26 versus 53 ± 27 /-LCi/mL x b (3-AB vs. PBS).
DISCUSSION
The present study provides both pharmacologic and genetic evidence that poly(ADP ribosyl)ation contributes to ischemic cell death, and that P ARP inhibition protects tissue within the ischemic territory. Mice deficient in P ARP were resistant to brain injury after transient focal The decreases in nicot inamide adenine dinucleotide (NAD) sta in ing after middle cerebral artery occlus ion (MCAO) were attenu ated after 3-aminobenzamide (3-AB) pretreatment. Nicotinamide adenine dinucleotide histochemistry was performed in coronal brain slices from phosphate-buffered sal ine-treated (left) and 3-AB-treated animals (right) 2 and 6 hours after 2-hour MCAO. Histochemical staining for NAD was performed with an enzymatic cycling method (N isslbaum et aI., 1969) modified for cryostat sections (12 IJm). Ni cotinamide adenine dinucleotide staining (dark color) is detected throughout the brain but is depleted in the territory of the left middle cerebral artery at 2 hours and more pronounced at 6 hours in vehicle-treated animals (left). Nicotinamide adenine dinucleotide depletion was less severe in 3-AB-treated an imals (r ight).
cerebral ischemia. Pharmacologic inhibition by 3-AB also conferred resi � tance to injury. Infarct sparing in both experiments was accompanied by improved Neurologi cal scores, suggesting that reduced PARP activity pre serves Neurological function. The differences between 3-AB and vehicle treated groups could not be explained by obvious effects on blood pressure or blood gases. These results recently have been confirmed by indepen dent studies on P ARP-I -mice (Eliasson et aI., 1997, in press ). Poly(ADP-ribose) immunoreactivity increased in isch emic tissue but only at early time points after reperfusion (5 minutes). The increase in immunoreactivity in ve hicle-treated animals did not sustain over time, possibly because of its short half-life (de Murcia and Menisser-de Murcia, 1994) . As expected, PARP-I -mice are deficient in poly(ADP-ribose) and remain so after MCAO. 3amino benz amide-treated mice also showed decreased poly(ADP-ribose) formation, which is in agreement with Heller et al. (1995) . Increases were less dramatic without reperfusion, as was protection by 3-AB treatment in a model of permanent ischemia (not shown). Thus, the extent of neuroprotection after P ARP inhibition/deletion may depend on the injury paradigm and the production of ROI and NO on reperfusion.
Poly(ADP-ribose)polymerase activation and subse quent depletion of NAD seem to be sequential events after the onset of reperfusion. Nicotinamide adenine di nucleotide levels decreased shortly after reperfusion in wild-type animals. Both 3-AB-treated mice and PARP Quantitat ive analys is showed no significant difference between groups.
knockout mice exhibited higher levels within the middle cerebral artery territory, suggesting that the mechanism of protection may relate to energy sparing. Our measure ments did not reflect the redox state of the tissue because we measured total NAD and not NADH/NAD+. Resyn thesis of NAD contributes to energy depletion because four molecules of adenosine triphosphate are needed to generate one molecule of NAD (Zhang et aI., 1994) . Under global ischemic conditions (Siesjo et aI., 1973; Pulsinelli al1d Duffy, 1983; Nowak et a!., 1985) , levels of adenosine triphosphate and adenosine, and indices of mi tochondrial function decrease minutes after global isch emia and return toward normal levels after 10 to 20 minutes, but not after longer ischemic periods (Phillis et a!., 1996) . Current data suggest that oxidative and deaminative DNA damage develops early during reperfusion, and that this is distinct from DNA laddering/oligonucleosomal damage. DNA damage is mediated in part by NO, ROl, and possibly other metabolites, causing base modifica tions, and single-and double-strand breaks (Tamir et aI., 1996) . Liu and colleagues (1996) provided evidence for free radical-mediated DNA damage during transient forebrain ischemia, e.g., 8-hydroxy-2' -deoxyguanosine formation and DNA strand breaks increase during reper fusion. We observed random DNA fragmentation early f after reperfusion whereas DNA laddering indicative of apoptosis was first evident 6 hours after 2 hours of focal cerebral ischemia and increased thereafter . Because DNA damage as judged by total DNA fragmentation, did not differ between groups in the pre sent study, this might indicate that DNA repair does not occur early after ischemia or that DNA repair mecha nisms are not impaired in PARP knockout and 3-AB treated animals, which is consistent with previous results .
Recently, several laboratories provided experimental evidence for apoptotic cell death in the ischemic border zone after MCAO (Li et aI., 1995a,b; Charriaut Marlangue et aI., 1996; MacManus et a!., 1996) . More over, inhibition of the CED-3 mammalian homologues, caspase-3 (CPP-32) and caspase-1 (interleukin-I [3converting enzyme) attenuates infarction after transient focal cerebral ischemia (Hara et aI., 1997a) , and smaller infarcts also were observed in transgenic mice express ing a dominant negative mutant of interleukin-l [3converting enzyme (Friedlander et aI., 1997; Hara et aI., 1997b) . Interestingly, PARP is a substrate for caspase-3, exhibiting only residual activity after cleavage. How ever, the functional role of PARP cleavage remains un clear. Because we did not observe differences in TUNEL cell density or DNA laddering within ischemic tissue in P ARP-I -and +1+ mice or 3-AB-treated animals com pared with controls, our results suggest that if P ARP deletion/inhibition blocks apoptosis in ischemia, it is not J Cereb Blood Flow Metab, Vol. 17. No.1 I. 1997
as robust as after administering peptide inhibitors of the interleukin-l[3-converting enzyme family (Endres et aI., 1997) . The decrease in the number of TUNEL-stained cells in the knockout/treatment group probably only re flects infarct sparing because the density of positive cells did not differ between groups. These findings are con sistent with studies by Liu et aI. (1997) , demonstrating that DNA fragmentation does not require the cleavage of PARP, and the fact that PARP knockout animals show no detectable defect in apoptosis during development (Wang et aI., 1995) . Of course, caspase-3 cleaves numer ous substrates, one or more of which might mediate ap optosis in ischemia by events unrelated to P ARP cleav age.
Thus, P ARP activation contributes to ischemic cell death in brain, and the mechanism-although still not completely understood-may relate primarily to the con sequences of depleting NAD levels. When given early, PARP inhibitors may be promising drugs for the treat ment of acute stroke in humans.
